Inventor · disambiguated record
Sergio Lociuro
Also filed as: LOCIURO SERGIO
24 granted patents·13 pending applications·196 citations·filing 1992–2025
95Inventor score
Top patents by PatentIndex Score
37 records- 0189US11207305B2Antibiotic combination therapiesBioVersys AG·Filed 2020·Granted Dec 28, 2021·2 cites·20 claims
- 0288US11766425B2Antibiotic combination therapiesBioVersys AG·Filed 2021·Granted Sep 26, 2023·1 cites·21 claims
- 0386US12403133B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2024·Granted Sep 2, 2025·0 cites·20 claims
- 0484US12257241B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2023·Granted Mar 25, 2025·0 cites·24 claims
- 0582US9518092B2Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activityPOLYPHOR LTD·Filed 2014·Granted Dec 13, 2016·4 cites·12 claims
- 0682US8895695B2Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activityZUMBRUNN JÜRG·Filed 2010·Granted Nov 25, 2014·9 cites·35 claims
- 0782US2025360115A1Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2025·Application pending·0 cites
- 0881US5891869ABasic oxazoline-amide derivatives of GE2270 and GE2270-like antibioticsBIOSEARCH ITALIA SPA·Filed 1996·Granted Apr 6, 1999·42 cites·47 claims
- 0980US11833139B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2022·Granted Dec 5, 2023·0 cites·16 claims
- 1080US7786078B2Template-fixed δ-hairpin peptidomimetics with CXCR4 antagonizing activityPOLYPHOR LTD·Filed 2004·Granted Aug 31, 2010·11 cites·32 claims
- 1179US11903934B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2022·Granted Feb 20, 2024·0 cites·10 claims
- 1278US7838496B2Template-fixed peptidomimetics as medicaments against HIV and cancerPOLYPHOR AG LTD·Filed 2003·Granted Nov 23, 2010·9 cites·17 claims
- 1378US2025281469A1Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2025·Application pending·0 cites
- 1472US11351158B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2020·Granted Jun 7, 2022·0 cites·21 claims
- 1572US6900183B2Macrolide antibioticsGLAXO GROUP LTD·Filed 2001·Granted May 31, 2005·7 cites·9 claims
- 1671US11344537B2Rifabutin treatment methods, uses, and compositionsBioVersys AG·Filed 2020·Granted May 31, 2022·0 cites·16 claims
- 1770US12370184B2Antibiotic combination therapiesBioVersys AG·Filed 2023·Granted Jul 29, 2025·0 cites·20 claims
- 1870US5786350A36-derivatives of rifamycins and their use as antimicrobial agentsLEPETIT SPA·Filed 1994·Granted Jul 28, 1998·26 cites·26 claims
- 1969US6143739ABasic proline-amide derivatives of GE 2270 and GE 2270-like antibioticsBIOSEARCH ITALIA SPA·Filed 1996·Granted Nov 7, 2000·31 cites·43 claims
- 2067US5599791AAmides of antibiotic GE 2270 factorsLEPETIT SPA·Filed 1992·Granted Feb 4, 1997·22 cites·13 claims
- 2164US6008225ADerivatives of antibiotic GE2270 factors C2a, D2 and EBIOSEARCH ITALIA SPA·Filed 1997·Granted Dec 28, 1999·29 cites·34 claims
- 2262US2025213575A18-heterocyclic-3-(phenylsulfonyl)-[1,2,3]triazolo[1,5a]quinazolin-5(4h)-one derivatives as anti-bacterialsBioVersys AG·Filed 2023·Application pending·0 cites
- 2362US2025376472A13-(phenylsulfonyl)-[1,2,3]triazolo[1,5a]quinazolin-5(4h)-one derivativesBioVersys AG·Filed 2023·Application pending·0 cites
- 2462US2020038399A1Formulations, methods, kit, and dosage forms for treating bacterial infectionMOTIF BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 2561US2023364065A1Antibiotic combination therapiesBioVersys AG·Filed 2022·Application pending·0 cites
- 2661US2025101039A1Rifamycin derivatives for the treatment of diseasesBioVersys AG·Filed 2023·Application pending·0 cites
- 2760US2025051356A1Rifabutin analogs for the treatment of diseaseBioVersys AG·Filed 2022·Application pending·0 cites
- 2860US2025235434A1Rifabutin analogs for the treatment of diseaseBioVersys AG·Filed 2023·Application pending·0 cites
- 2957US7202221B2MacrolidesPLIVA D D·Filed 2002·Granted Apr 10, 2007·3 cites·9 claims
- 3055US2018133218A1Formulations, methods, kit, and dosage forms for treating bacterial infectionMOTIF BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 3148US12509462B23-(phenylsulfonyl)-[1,2,3]triazolo[1,5A]quinazolin-5(4H)-one derivativesBioVersys AG·Filed 2019·Granted Dec 30, 2025·0 cites·18 claims
- 3246US10717757B2Ketolides having antibacterial activityBIOPHARMATI SA·Filed 2019·Granted Jul 21, 2020·0 cites·5 claims
- 3346US7696249B2Diphenyl urea derivativesARPIDA AG·Filed 2006·Granted Apr 13, 2010·0 cites·14 claims
- 3446US2006211636A1Macrolide AntibioticsALIHODZIC SULEJMAN·Filed 2006·Application pending·0 cites
- 3543US2005215495A1Macrolide antibioticsALIHODZIC SULEJMAN·Filed 2005·Application pending·0 cites
- 3642US2004077557A1Macrolide antibioticsFiled 2001·Application pending·0 cites
- 3733US7262172B2MacrolidesGLAXOSMITHKLINE ZAGREB·Filed 2001·Granted Aug 28, 2007·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Sergio Lociuro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →